Mangifera indica L. extract (Vimang) improves the aversive memory in spinocerebellar ataxia type 2 transgenic mice.
Context: The spinocerebellar ataxia type 2 (SCA-2) is a progressive neurodegenerative disorder without specific therapy identified, and it is related to the loss of function in the cerebellum, mitochondrial dysfunction, oxidative stress and neurotoxic processes. Scientific evidence indicates that Ma...
Main Authors: | Natasha Maurmann, Caroline B. de Farias, Gilberto Schwartsmann, Rafael Roesler, René Delgado-Hernández, Gilberto L. Pardo-Andreu |
---|---|
Format: | Article |
Language: | English |
Published: |
GarVal Editorial Ltda.
2014-06-01
|
Series: | Journal of Pharmacy & Pharmacognosy Research |
Subjects: | |
Online Access: | http://jppres.com/jppres/pdf/vol2/jppres14.030_2.3.63.pdf |
Similar Items
-
Evaluación de la acción cicatrizante del Vimang® en un modelo experimental de ratas con quemaduras
by: Sady Valdés Mesa, et al.
Published: (2022-10-01) -
A Mangifera indica L. Extract Could Be Used to Treat Neuropathic Pain and Implication of Mangiferin
by: María del C. Rabí, et al.
Published: (2010-12-01) -
Effect of commercial (vimang) and hydroalcoholic extract of Mangifera indica (Mango) on gentamicin-induced nephrotoxicity in rat
by: Abolfazl Khajavi Rad, et al.
Published: (2011-09-01) -
Spinocerebellar ataxias Ataxias espinocerebelares
by: Hélio A.G. Teive
Published: (2009-12-01) -
A trial of topiramate for patients with hereditary spinocerebellar ataxia
by: Shiroh Miura, et al.
Published: (2023-02-01)